Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52:197-203.
Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007;19:430-440.
Ackerman AB. "Dysplastic nevus" syndrome: does a survey make it real? J Am Acad Dermatol. 2003;48:461-463.
Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008;128:2365-2380.
Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325:171-182.
Larsen F, Cockerell CJ. The dysplastic nevus concept. Pathology Case Rev. 2007;12:240-244.
Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617-628.
Campos-do-Carmo G, Ramos-e-Silva M. Dermatoscopy: basic concepts. Int J Dermatol. 2008;47:712-719.
Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012;67:1.e1-1.e16.
Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012;67:19.e1-19.e12.
Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol. 2009;145:816-826.
1. McKee PH, Calonje E, Granter SR, eds. Pathology of the skin. 3rd ed. London: Elsevier; 2005.
2. Argenziano G, Zalaudek I, Ferrara G, et al. Proposal of a new classification system for melanocytic naevi. Br J Dermatol. 2007;157:217-227.
3. Schmoeckel, C. Classification of melanocytic nevi: do nodular and flat nevi develop differently? Am J Dermatopathol. 1997;19:31-34.
4. Burkhart CG. Dysplastic nevi. N Engl J Med. 2004;350:1258-1259.
5. Bolognia JL, Jorizzo JL, Rapini RP, et al. Dermatology. 2nd ed. New York, NY: Mosby; 2008.
6. Tannous ZS, Mihm MC Jr, Sober AJ, et al. Congenital melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management. J Am Acad Dermatol. 2005;52:197-203.
7. Schaffer JV. Pigmented lesions in children: when to worry. Curr Opin Pediatr. 2007;19:430-440.
8. Dulon M, Weichenthal M, Blettner M, et al. Sun exposure and number of nevi in 5- to 6- year-old European children. J Clin Epidemiol. 2002;55:1075-1081.
9. Maize JC, Foster G. Age-related changes in melanocytic naevi. Clin Exp Dermatol. 1979;4:49-58.
10. Coleman WP 3rd, Gately LE 3rd, Krementz AB, et al. Nevi, lentigines, and melanoma in blacks. Arch Dermatol. 1980;116:548-551.
11. Gallagher RP, Rivers JK, Lee TK, et al. Broad-spectrum sunscreen use and the development of new nevi in white children: a randomized controlled trial. JAMA. 2000;283:2955-2960.
12. Warner PM, Yakuboff KP, Kagan RJ, et al. An 18-year experience in the management of congenital nevomelanocytic nevi. Ann Plast Surg. 2008;60:283-287.
13. Ackerman AB. "Dysplastic nevus" syndrome: does a survey make it real? J Am Acad Dermatol. 2003;48:461-463.
14. Valiukeviciene S, Miseviciene I, Gollnick H. The prevalence of common acquired melanocytic nevi and the relationship with skin type characteristics and sun exposure among children in Lithuania. Arch Dermatol. 2005;141:579-586.
15. Wachsmuth RC, Turner F, Barrett JH, et al. The effect of sun exposure in determining nevus density in UK adolescent twins. J Invest Dermatol. 2005;214:56-62.
16. Rivers JK, Maclennan R, Kelly JW, et al. The eastern Australian childhood nevus study: prevalence of atypical nevi, congenital nevus-like nevi, and other pigmented lesions. J Am Acad Dermatol. 1995;32:957-963.
17. Gallagher RP, McLean DI. The epidemiology of acquired melanocytic nevi: a brief review. Dermatol Clin. 1995;13:595-603.
18. Grichnik JM. Melanoma, nevogenesis, and stem cell biology. J Invest Dermatol. 2008;128:2365-2380.
19. Burkhart CG, Burkhart CN. The mole theory: primary function of melanocytes and melanin may be antimicrobial defense and immunomodulation (not solar protection). Int J Dermatol. 2005;44:340-342.
20. Koh HK. Cutaneous melanoma. N Engl J Med. 1991;325:171-182.
21. Harrison SL, MacLennan R, Buettner PG. Sun exposure and the incidence of melanocytic nevi in young Australian children. Cancer Epidemiol Biomarkers Prev. 2008;17:2318-2324.
22. Kelly JW, Rivers JK, MacLennan R, et al. Sunlight: a major factor associated with the development of melanocytic nevi in Australian schoolchildren. J Am Acad Dermatol. 1994;30:40-48.
23. American Academy of Dermatology. Body mole map. http://www.aad.org (last accessed 1 August 2017).
24. American Melanoma Foundation. ABCD's of melanoma. 2006. http://www.melanomafoundation.org (last accessed 1 August 2017).
25. Schaffer JV, Orlow SJ, Lazova R, et al. Speckled lentiginous nevus: within the spectrum of congenital melanocytic nevi. Arch Dermatol. 2001;137:172-178.
26. Cyr PR. Atypical moles. Am Fam Physician. 2008;78:735-740.
27. Larsen F, Cockerell CJ. The dysplastic nevus concept. Pathology Case Rev. 2007;12:240-244.
28. Salopek TG. The dilemma of the dysplastic nevus. Dermatol Clin. 2002;20:617-628.
29. Grob JJ, Bonerandi JJ. The ugly duckling sign: identification of the common characteristics of nevi in an individual as a basis for melanoma screening. Arch Dermatol. 1998;134:103-104.
30. Campos-do-Carmo G, Ramos-e-Silva M. Dermatoscopy: basic concepts. Int J Dermatol. 2008;47:712-719.
31. Smith L, Macneil S. State of the art in non-invasive imaging of cutaneous melanoma. Skin Res Technol. 2011;17:257-269.
32. Brehmer F, Ulrich M, Haenssle HA. Strategies for early recognition of cutaneous melanoma - present and future. Dermatol Pract Conc. 2012;2:6.
33. Walter FM, Morris HC, Humphrys E, et al. Protocol for the MoleMate UK Trial: a randomised controlled trial of the MoleMate system in the management of pigmented skin lesions in primary care [ISRCTN 79932379]. BMC Fam Pract. 2010;11:36.
34. Moncrieff M, Cotton S, Claridge E, et al. Spectrophotometric intracutaenous analysis: a new technique for imagining pigmented skin lesions. Br J Dermatol. 2002;146:448-457.
35. Mackie RM, Doherty VR. Seven-point checklist for melanoma. Clin Exp Dermatol. 1991;16:151-153.
36. Walter FM, Morris HC, Humphrys E, et al. Effect of adding a diagnostic aid to best practice to manage suspicious pigmented lesions in primary care: randomised controlled trial. BMJ. 2012;345:e4110.
37. Elbaum M, Kopf AW, Rabinovitz HS, et al. Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol. 2001;44:207-218.
38. Bolognia JL. Biopsy techniques for pigmented lesions. Dermatol Surg. 2001;26:89-90.
39. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era: part I. Historical, histologic, and clinical aspects. J Am Acad Dermatol. 2012;67:1.e1-1.e16.
40. Duffy K, Grossman D. The dysplastic nevus: from historical perspective to management in the modern era. Part II. Molecular aspects and clinical management. J Am Acad Dermatol. 2012;67:19.e1-19.e12.
41. Arneja JS, Gosain AK. Giant congenital melanocytic nevi. Plast Reconstr Surg. 2009;124(1 Suppl):1e-13e.
42. Marghoob AA, Kopf AW. Persistent nevus: an exception to the ABCD rule of dermoscopy. J Am Acad Dermatol. 1997;36:474-475.
43. Kornber R, Ackerman AB. Pseudomelanoma: recurrent melanocytic nevus following partial surgical removal. Arch Dermatol. 1975;111:1588-1590.
44. New Zealand Guidelines Group. Clinical practice guidelines for the management of melanoma in Australia and New Zealand. June 2008. http://www.health.govt.nz (last accessed 1 August 2017).
45. Strazzula L, Vedak P, Hoang MP, et al. The utility of re-excising mildly and moderately dysplastic nevi: a retrospective analysis. J Am Acad Dermatol. 2014;71:1071-1076.
46. Reddy KK, Farber MJ, Bhawan J, et al. Atypical (dysplastic) nevi: outcomes of surgical excision and association with melanoma. JAMA Dermatol. 2013;149:928-934.
47. Abello-Poblete MV, Correa-Selm LM, Giambrone D, et al. Histologic outcomes of excised moderate and severe dysplastic nevi. Dermatol Surg. 2014;40:40-45.
48. Gerami P, Scolyer RA, Xu X, et al. Risk assessment for atypical spitzoid melanocytic neoplasms using FISH to identify chromosomal copy number aberrations. Am J Surg Pathol. 2013;37:676-684.
49. Gerami P, Li G, Pouryazdanparast P, et al. A highly specific and discriminatory FISH assay for distinguishing between benign and malignant melanocytic neoplasms. Am J Surg Pathol. 2012;36:808-817.
50. Tanaka M. Dermoscopy. J Dermatol. 2006;33:513-517.
51. Zalaudek I, Docimo G, Argenziano G. Using dermoscopic criteria and patient-related factors for the management of pigmented melanocytic nevi. Arch Dermatol. 2009;145:816-826.
52. American Cancer Society. Cancer facts and figures 2008. http://www.cancer.org (last accessed 1 August 2017).
53. Rigel DS. Cutaneous ultraviolet exposure and its relationship to the development of skin cancer. J Am Acad Dermatol. 2008;58(suppl 2):S129-S132.
54. Olsen CM, Carroll HJ, Whiteman DC. Estimating the attributable fraction for cancer: a meta-analysis of nevi and melanoma. Cancer Prev Res (Phila). 2010;3:233-245.
55. Smack DP, Harrington AC, Dunn C, et al. Infection and allergy incidence in ambulatory surgery patients using white petrolatum vs bacitracin ointment. A randomized controlled trial. JAMA. 1996;276:972-977.
56. Campbell RM, Perlis CS, Fisher E, et al. Gentamicin ointment versus petrolatum for management of auricular wounds. Dermatol Surg. 2005;31:664-669.
57. Gette MT, Marks JG Jr, Maloney ME. Frequency of postoperative allergic contact dermatitis to topical antibiotics. Arch Dermatol. 1992;128:365-367.
58. Suzuki H, Anderson RR. Treatment of melanocytic nevi. Dermatol Ther. 2005;18:217-226.
59. Polder KD, Landau JM, Vergilis-Kalner IJ, et al. Laser eradication of pigmented lesions: a review. Dermatol Surg. 2011;37:572-595.
60. Lee PK, Rosenberg CN, Tsao H, et al. Failure of Q-switched ruby laser to eradicate atypical-appearing solar lentigo: report of two cases. J Am Acad Dermatol. 1998;38:314-317.
61. Gottschaller C, Hohenleutner U, Landthaler M. Metastasis of a malignant melanoma 2 years after carbon dioxide laser treatment of a pigmented lesion: case report and review of the literature. Acta Derm Venereol. 2006;86:44-47.
62. Woodrow SL, Burrows SN. Malignant melanoma occurring at the periphery of a giant congenital naevus preciously treated with laser therapy. Br J Dermatol. 2003;149:886-888.
63. Dummer R, Kempf W, Burg G. Pseudo-melanoma after laser therapy. Dermatology. 1998;197:71-73.
64. Elder DE, Elenitsas R, Johnson BL, eds. Lever's histopathology of the skin. 10th ed. Philadelphia, PA: Lippincott Williams and Wilkins; 2009.
65. Cancer Research UK. Skin cancer statistics - key facts. May 2012. http://www.cancerresearchuk.org (last accessed 1 August 2017).
66. Herzog C, Pappo A, Bondy M, et al. Malignant melanoma. In: Bleyer A, O'Leary M, Barr R, et al, eds. Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975-2000. Bethesda, MD: National Cancer Institute; 2006:53-64.
67. Vourc'h-Jourdain M, Martin L, Barbarot S; aRED. Large congenital melanocytic nevi: therapeutic management and melanoma risk: a systematic review. J Am Acad Dermatol. 2013;68:493-498.
68. Kanzler MH, Mraz-Gernhard S. Primary cutaneous malignant melanoma and its precursor lesions: diagnostic and therapeutic overview. J Am Acad Dermatol. 2001;45:260-276.
69. Clark WH Jr, Reimer RR, Greene M, et al. Origin of familial malignant melanomas from heritable melanocytic lesions: 'the B-K mole syndrome'. Arch Dermatol.1978;114:732-738.
70. Tsao H, Sober AJ, Niendorf KB, et al. Case records of the Massachusetts General Hospital: a 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma. N Engl J Med. 2004;350:924-932.
71. de Maleissye MF, Beauchet A, Saiag P, et al. Sunscreen use and melanocytic nevi in children: a systematic review. Pediatr Dermatol. 2013;30:51-59.
72. Crane LA, Deas A, Mokrohisky ST, et al. A randomized intervention study of sun protection promotion in well-child care. Prev Med. 2006;42:162-170.
73. Menzies SW. Is sun exposure a major cause of melanoma? Yes. BMJ. 2008;337:a763.
74. Eide MJ, Weinstock MA. Association of UV index, latitude, and melanoma incidence in nonwhite populations - US surveillance, epidemiology, and end results (SEER) program, 1992 to 2001. Arch Dermatol. 2005;141:477-481.
75. Shuster S. Is sun exposure a major cause of melanoma? No. BMJ. 2008;337:a764.
使用此内容应接受我们的免责声明。
BMJ临床实践的持续改进离不开您的帮助和反馈。如果您发现任何功能问题和内容错误,或您对BMJ临床实践有任何疑问或建议,请您扫描右侧二维码并根据页面指导填写您的反馈和联系信息*。一旦您的建议在我们核实后被采纳,您将会收到一份小礼品。
如果您有紧急问题需要我们帮助,请您联系我们。
邮箱:bmjchina.support@bmj.com
电话:+86 10 64100686-612
*您的联系信息仅会用于我们与您确认反馈信息和礼品事宜。
BMJ临床实践官方反馈平台